In 2025, the AI landscape is undergoing a transformative shift, expanding into two critical new layers: the application layer ...

A revolutionary personalized cancer vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and ...

The bill's sponsor said that restriction was “an error,” and that she intends to change it if it were to move forward in the ...

Tissue processing advance can label proteins at the level of individual cells across whole, intact rodent brains and other large samples just as fast and uniformly as in dissociated single cells.

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” could have ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine.

But ever since the 2019 global health crisis, one of the biggest areas of interest to capture attention have been how we receive vaccines and other treatments, from mRNA, to sublingual ... the FDA ...